← Every applicant
Strides Pharma Intl FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATENew drugNov 22, 2023SOLUTION, ORAL |
| SEVELAMER CARBONATENew drugSep 8, 2023FOR SUSPENSION, ORAL |
| MYCOPHENOLATE MOFETILNew drugAug 29, 2023FOR SUSPENSION, ORAL |
| BUPRENORPHINENew drugMay 17, 2022FILM, EXTENDED RELEASE, TRANSDERMAL |
| LYVISPAHNew drugNov 22, 2021GRANULE, ORAL |